Biotron

Biotron Limited (BIT) is a clinical stage Australian Biotechnology Company based in Sydney, Australia. The company is involved in the development and commercialization of a novel small molecule approach that has the potential to treat several serious viral diseases. The technology targets viroporin proteins which enables the pathogenicity of several viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus (RSV). The company has operations in Australia.

Contact Details

, SYDNEY

pnightingale@biotron.com.au

www.biotron.com.au

Lists and Charts

Share price

Biotron
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1810^th	/Company/Blue-Star-Helium	-82.5%	-11.65%
1811^th	/Company/Green-Technology-Metals	-82.68%	0%
1812^th	/Company/Biotron	-82.69%	-21.82%
1813^th	/Company/GreenTech-Metals	-83.01%	0%
1814^th	/Company/TG-Metals	-83.03%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	REMUNERATION UPDATE: Michael Hoy, Non-Executive Chairman, Non-Executive Director	03 Nov 2020
	REMUNERATION UPDATE: Robert Thomas, Non-Executive Director	03 Nov 2020
	REMUNERATION UPDATE: Susan Pond, Non-Executive Director	03 Nov 2020
	REMUNERATION UPDATE: Michelle Miller, Managing Director	03 Nov 2020
	REMUNERATION UPDATE: Peter Nightingale, Company Secretary	03 Nov 2020
	NEW ROLE: Stephen A Locarnini, Non-Executive Director	03 Nov 2020

News Articles

Related Information

Access to our data for Biotron is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Biotron is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today